Publicaciones en colaboración con investigadores/as de Pierre and Marie Curie University (30)

2023

  1. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

    Annals of the rheumatic diseases, Vol. 82, Núm. 5, pp. 698-709

  2. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers

    Annals of the Rheumatic Diseases

  3. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al

    Annals of the Rheumatic Diseases

  4. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al

    Annals of the Rheumatic Diseases

2022

  1. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

    The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613

  2. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

    RMD Open, Vol. 8, Núm. 2

  3. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 10, pp. 1344-1347

  4. Intra-articular therapies: patient preferences and professional practices in European countries

    Rheumatology International, Vol. 42, Núm. 5, pp. 869-878

  5. SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases

    Annals of the rheumatic diseases

  6. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

    RMD Open, Vol. 8, Núm. 2

  7. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

    Annals of the rheumatic diseases, Vol. 81, Núm. 5, pp. 695-709

2021

  1. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 707-713

  2. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1137-1146

  3. EULAR COVID-19 registry: Lessons learnt and future considerations

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1110-1115

  4. EULAR recommendations for intra-articular therapies

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 10, pp. 1299-1305

  5. Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: An overview of systematic reviews

    RMD Open, Vol. 7, Núm. 2

  6. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

    The Lancet Rheumatology, Vol. 3, Núm. 12, pp. e855-e864

2020

  1. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 859-866

  2. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 851-858

  3. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 11, pp. 1423-1431